Skip to content

A study on how a scoring system helps guide surgery and improve outcomes in lomg term pancreatitis patients

Chronic Pancreatitis Prognosis Score(COPPS)-Guided Surgery for Chronic Pancreatitis:A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111029
Enrollment
58
Registered
2026-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: Group B: Surgical management : Patients will be undergoing Frey Procedure Control Intervention1: Group A: Medical management: Patients will be taking standard medical therapy

Sponsors

IPGMER SSKMH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults more than equal to 18 years diagnosed with CP as per the above definition having a severity of COPPS 2. Willing to give informed consent.

Exclusion criteria

Exclusion criteria: 1. Acute pancreatitis (defined by Revised Atlanta Classifation) or acute-on-chronic pancreatitis at the time of inclusion 2. CP patients with COPPS-A and COPPS-C severity at enrollment 3. Previous pancreatic surgery and/or pancreatic endotherapy 4. Confirmed pancreatic malignancy (on Endoscopic Ultrasound guided FNA of any solid mass lesion seen on Imaging) 5. Patients with significant co-morbidities (as defined by Charlson s co-morbidity index more than equal to 2) making them high-risk for surgery-related complications 6. Pregnant Women 7. Human Immunodeficiency Virus Infection 8. Patients not giving Informed consent for inclusion in an RCT

Design outcomes

Primary

MeasureTime frame
Proportion of patients needing at least one hospitalization for pain ( acute exacerbation) during a follow-up period of 12 monthsTimepoint: Proportion of patients needing at least one hospitalization for pain ( acute exacerbation) during a follow-up period of 12 months

Secondary

MeasureTime frame
1. Proportion of patients needing at least one hospitalization for any cause during a follow-up period of 12 months 2. Total number of hospitalizations (all reasons) during the 12 months follow-up 3. Total number of days spent in hospital during the 12 months follow-up 4. Total number of days in which oral analgesics was consumed during the 12 months follow-up Timepoint: At 12 months

Countries

India

Contacts

Public ContactAkash Karmakar

IPGMER SSKMH

dockdas@gmail.com9830349787

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026